Using a different methodology and risk score categories, Vicenzi et al.27described the added value of the TAPSE/sPAP ratio, along with other parameters of RV function to improve the risk stratification of patients with PAH. This evidence concerns the gene PDZK1IP1 and pulmonary arterial hypertension.